Winning Health Technology Group Co., Ltd. (SHE:300253)
China flag China · Delayed Price · Currency is CNY
11.06
-0.34 (-2.98%)
At close: Feb 13, 2026

SHE:300253 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Jan '23 Jan '22 Dec '20
Operating Revenue
2,1642,7823,1613,0912,7492,264
Other Revenue
0.440.442.471.380.942.23
2,1652,7823,1633,0932,7502,267
Revenue Growth (YoY)
-31.84%-12.05%2.28%12.46%21.34%18.79%
Cost of Revenue
1,4121,6231,7411,7421,4761,041
Gross Profit
752.631,1591,4231,3511,2751,226
Selling, General & Admin
490.71545.37653.83707.67585.95464.12
Research & Development
296.24264.63333.3313.77255.67229.45
Other Operating Expenses
-108.51-107.76-99.2825.8-79.54-80.1
Operating Expenses
863.04888.611,0271,282995.35748.5
Operating Income
-110.41270.25395.2869.54279.34477.18
Interest Expense
-66.68-66.76-64.05-59.63-46.68-9.88
Interest & Investment Income
7.5310.1443.0920.6211.8105.82
Currency Exchange Gain (Loss)
---0.01-0-0.02
Other Non Operating Income (Expenses)
-62.53-5.320.78-14.25-22.38-10.3
EBT Excluding Unusual Items
-232.09208.31375.0916.28222.08562.81
Impairment of Goodwill
-63.64-63.64-6.6-22.94--
Gain (Loss) on Sale of Investments
-85.99-76.83-50.46-90.56116.51-34.69
Gain (Loss) on Sale of Assets
1.72-0.28-0.43-0.520.180.23
Asset Writedown
2.62-0.09-0.05-0.31-0.31-0.69
Legal Settlements
---0.26---
Other Unusual Items
19.4919.4923.46136.634.7218.5
Pretax Income
-357.8886.96340.7538.54373.17546.16
Income Tax Expense
-22.7536.8923.1323.7819.4340.63
Earnings From Continuing Operations
-335.1450.07317.6214.76353.73505.53
Minority Interest in Earnings
27.0137.8340.3493.8824.44-14.43
Net Income
-308.1287.89357.96108.64378.17491.1
Net Income to Common
-308.1287.89357.96108.64378.17491.1
Net Income Growth
--75.45%229.49%-71.27%-22.99%23.26%
Shares Outstanding (Basic)
2,1912,1542,1472,1392,1432,125
Shares Outstanding (Diluted)
2,1912,1602,1952,1432,1472,138
Shares Change (YoY)
0.51%-1.60%2.42%-0.22%0.44%1.15%
EPS (Basic)
-0.140.040.170.050.180.23
EPS (Diluted)
-0.140.040.160.050.180.23
EPS Growth
--75.05%221.70%-71.21%-23.34%21.86%
Free Cash Flow
242.81101.71-128.53-223.2681.83203.36
Free Cash Flow Per Share
0.110.05-0.06-0.100.040.10
Dividend Per Share
0.0150.0150.0200.0100.0200.025
Dividend Growth
-25.00%-25.00%100.00%-50.00%-20.00%30.21%
Gross Margin
34.77%41.65%44.97%43.69%46.35%54.08%
Operating Margin
-5.10%9.71%12.50%2.25%10.16%21.05%
Profit Margin
-14.23%3.16%11.32%3.51%13.75%21.67%
Free Cash Flow Margin
11.22%3.66%-4.06%-7.22%2.97%8.97%
EBITDA
-86.64293.17417.0690.9299.2495.7
EBITDA Margin
-4.00%10.54%13.18%2.94%10.88%21.87%
D&A For EBITDA
23.7722.9121.7721.3519.8618.52
EBIT
-110.41270.25395.2869.54279.34477.18
EBIT Margin
-5.10%9.71%12.50%2.25%10.16%21.05%
Effective Tax Rate
-42.42%6.79%61.71%5.21%7.44%
Revenue as Reported
2,1652,7823,1633,0932,7502,267
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.